| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Alzamend Neuro, Inc. (ALZN) has 3 insiders with recent SEC Form 4 filings, including 6 buys and 8 sells. ALZN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 25 | $26.15 | - | |
| Dir | 0 | - | - | |
| Dir | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 31, 2025 | Ault Milton C III | Director, 10% Owner | Sell | 129,449 | $2.28 | $295,531.78 | -52.6% | +9.1% | - | |
| Jul 28, 2025 | Ault Milton C III | Director, 10% Owner | Sell | 44,843 | $2.86 | $128,169.33 | -34.9% | -11.6% | - | |
| Jul 24, 2025 | Ault Milton C III | Director, 10% Owner | Sell | 69,137 | $2.95 | $203,820.78 | -28.4% | -21.7% | - | |
| May 12, 2025 | Ault Milton C III | Director, 10% Owner | Sell | 1,224 | $5.06 | $6,196.35 | -10.8% | -53.4% | -79.2% | |
| Mar 26, 2025 | Horne William B. | Director | Buy | 3,334 | $0.99 | $3,285.32 | +12.5% | -67.4% | -83.3% | |
| Mar 21, 2025 | Katzoff David J | Chief Financial Officer | Buy | 5,000 | $1.01 | $5,048.00 | +925.9% | -66.6% | -79.9% | |
| Mar 21, 2025 | Ault Milton C III | Director, 10% Owner | Buy | 2,905 | $1.02 | $2,968.91 | +3.5% | -66.6% | -79.9% | |
| Mar 20, 2025 | Horne William B. | Director | Buy | 5,000 | $0.98 | $4,891.50 | +23.1% | -65.7% | -79.2% | |
| Mar 18, 2025 | Ault Milton C III | Director, 10% Owner | Buy | 5,000 | $0.96 | $4,810.00 | +6.5% | -63.5% | -77.3% | |
| Mar 18, 2025 | Horne William B. | Director | Buy | 5,000 | $0.97 | $4,851.50 | +30.0% | -63.5% | -77.3% |